Does pravastatin reduce coronary events in patients after myocardial infarction with average cholesterol levels?
Pravastatin provides clinical benefit in reducing coronary events for post-myocardial infarction patients even when their cholesterol levels are average.
These results demonstrate that the benefit of cholesterol-lowering therapy extends to the majority of patients with coronary disease who have average cholesterol levels.
Sacks et al. (1996) studied this question.